META vs MRK: Which Is the Better Buy?
Side-by-side comparison of Meta Platforms, Inc. and Merck & Co., Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-07-20.
Meta Platforms, Inc. · Communication Services
$646.01
+43.0% upside to fair value
High Conviction
Grade A
High Quality
VS
Merck & Co., Inc. · Healthcare
$113.87
-12.1% upside to fair value
Grade D
High Quality
QuantHub Verdict
META has more upside to fair value
(+43.0%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
META |
MRK |
| Current Price |
$646.01 |
$113.87 |
| Fair Value Estimate |
$924.09 |
$100.14 |
| Upside to Fair Value |
+43.0%
|
-12.1%
|
| Market Cap |
$1,639.8B |
$281.2B |
| Forward P/E |
—
|
32.0x
|
| EV / EBITDA |
15.0x
|
17.3x
|
| Price / Sales |
7.6x
|
4.3x
|
| Price / FCF |
33.9x
|
19.9x
|
| Revenue Growth YoY |
+33.1%
|
+4.3%
|
| Gross Margin |
81.9%
|
75.9%
|
| Operating Margin |
41.2%
|
27.6%
|
| Return on Equity |
33.2%
|
17.9%
|
| Dividend Yield |
0.33% |
0% |
| FCF Yield |
2.95%
|
5.02%
|
| Analyst Consensus |
Strong Buy
|
Hold
|
Investment Thesis
Meta Platforms operates the Facebook, Instagram, Messenger and WhatsApp ecosystem and monetizes its 3.56 billion Family daily active people primarily through digital advertising. Business quality is high: the core platform combines global network effects, advertiser measurement data, creator supply, cross-app distribution and AI-driven ad ranking, supporting 81.9% gross margin, 41.2% operating ma…
Merck & Co., Inc. is a leading global healthcare company specializing in pharmaceuticals, vaccines, and animal health products. Its business quality is high, supported by a durable competitive moat anchored in the dominant global position of Keytruda in PD-1/PD-L1 oncology, a strong vaccines portfolio including Gardasil, and scale in R&D and manufacturing. The company benefits from a seasoned lea…
Accumulation Zones
| Metric |
META |
MRK |
| Zone Low |
$693.07 |
$75.11 |
| Zone High |
$785.48 |
$85.12 |
| In Buy Zone? |
Yes
|
No
|